antimicrobial resistance
Top Five Articles on 360Dx Last Week: Test for COPD Flare-Ups; Clinical Use of Wearable Techs; More
Last week, readers were most interested in a story about the development of an AI-based method to predict COPD flare-ups before symptoms appear.
The UK-based firm is developing its initial panel tests for Gram-negative bacteria with tests for Gram-positive bacteria and fungal infections to follow.
Top Five Articles on 360Dx Last Week: Tempus Buy of Ambry Genetics; Blood-Based MRD Testing; More
Last week, readers were most interested in a story about Tempus' expectations for its acquisition of cancer testing firm Ambry.
Antimicrobial Susceptibility Tech Firm iFast Diagnostics Raises $6.5M
The UK-based company is developing a platform to help determine the best antibiotic treatment for individual patients.
Diasorin Submits Gram-Negative Bacteria Panel for FDA 510(k) Clearance
The firm's Gram-negative blood culture assay is used to identify bacterial pathogens and drug resistances, with results within two hours of a Gram stain.